Log In
Print this Print this

Biosimilar recombinant coagulation factor IX (GNR-003)

  Manage Alerts
Collapse Summary General Information
Company International Biotech Center Generium (IBC Generium)
DescriptionHuman blood coagulation factor IX
Molecular Target
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II/III
Standard IndicationHemophilia
Indication DetailsTreat hemophilia type B
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today